Footwear; parts of clothing, footwear and headgear.

Education, entertainment and sport services.

Smartwatches; smartglasses; smart rings; computer programs, recorded; downloadable computer software programs; wearable activity trackers; data processing apparatus; pedometers; smartphones; headsets; cabinets for loudspeakers; educational apparatus and instruments; computers; camcorders; chargers for electric accumulators; facial recognition devices; sensors; pressure measuring apparatus; velocity sensors; measuring apparatus.

Apparatus for use in medical analysis; physiotherapy apparatus; infrared thermometers for medical purposes; heart rate monitoring apparatus; massage apparatus; testing apparatus for medical purposes; diagnostic apparatus for medical purposes; body fat monitors; sphygmomanometers; body composition monitors.

Computer software; software for managing, integrating and facilitating connectivity with medical care data.

Medical apparatus for tracking, diagnosis and analysis for medical use.

Energy drinks; Coconut water (beverages); Bottled fruit drinks; Bottled fruit juices; Bottled water (not for medical purposes); Coconut juice (beverages); Beverages consisting of a blend of fruit and vegetable juices; Aerated fruit juices; Aerated juices; Sports drinks (non-medicated); Tonic water (non-medicated beverages); Beverages made from fruit concentrates; Frozen concentrated fruit drinks; Frozen concentrated fruit juices; Concentrates for use in the preparation of soft drinks; Liquid mixtures for making soft drinks; Soft drinks; Protein-enriched sports beverages; Electrolyte replacement beverages for general and sports purposes; Extracts of vegetables (beverages); Fruit juice extracts for use as a beverage; Fresh fruit juices; Fresh vegetable juices; Frozen vegetable juices; Vegetable drinks; Vegetable extracts for use in the preparation of non-alcoholic drinks; Aerated beverages (non-alcoholic); Aerated drinks (non-alcoholic); Aloe vera drinks, non alcoholic; Ades [non-alcoholic fruit-based drinks]; Ades [non-alcoholic sweetened drinks of diluted fruit juices]; Natural spring waters (not for medical purposes); Natural water (not for medical purposes); Non-medicated mineral drinks; Non-medicated mineral spring waters; Natural mineral water (not for medical purposes); Aerated mineral waters; Mineral water (beverages); Flavoured water beverages; Fruit flavoured non-alcoholic drinks; Fruit flavoured squashes; Mixtures of fruit flavoured drinks; Alcohol-free beverages; Alcohol-free drinks; Alcohol-free cider

Business advice relating to marketing; Business administration consultancy; Business consultancy; Business consultancy relating to franchising; Advertising; Arranging and conducting promotional and marketing events; Business promotion services; Export promotion services; Point of purchase promotions (for others); Promotion (advertising) of business; Promotion of goods and services through sponsorship of sports events; Promotional advertising services; Promotional marketing; Promotional services; Sales promotion (for others); Sales promotion services; Sales promotions at point of purchase or sale (for others); Business organisation and management of discount services; Online retail services; Discount store services (retail, wholesale, or sales promotion services); Business management of a retail enterprise for others; Convenience store retailing; Department store retailing; Retail services; Retailing of goods (by any means); Retailing of goods via a vending machine; The bringing together, for the benefit of others, a variety of goods (excluding the transport thereof), enabling customers to conveniently view and purchase the goods; Distribution of advertising material; Distribution of goods for advertising purposes; Distribution of samples

Soccer shoes; Football boots; Football shoes; Studs for football boots; Studs for football shoes; Surf shorts; Surfing shorts; Swimming shorts; Boxer shorts; Hockey shorts; Rugby shorts; Football jerseys; Rugby jerseys; Football shirts; Baseball shirts; Rugby shirts

Smartwatches [data processing apparatus]; smart rings [data processing apparatus]; smartglasses [data processing apparatus]; encoded identification bracelets, magnetic; computer programs, recorded; computer peripheral devices; mobile phone software applications, downloadable; data processing apparatus; electronic and magnetic identity cards for use in connection with payment services; time recording apparatus; counters; pedometers; wearable computers; apparatus to check franking; automated teller machines [ATM]; mechanisms for coin-operated apparatus; dictating machines; holograms; hemline markers; voting machines; computer software applications, downloadable; cell phones; wearable activity trackers; wrist-mounted smartphones; smartphones in the shape of a watch; wearable video display monitors; face recognition apparatus; phototelegraphy apparatus; scales; measures; digital signs; cameras [photography]; measuring apparatus; distance measuring apparatus; taximeters; connected bracelets [measuring instruments]; apparatus and instruments for physics; measuring devices, electric; simulators for the steering and control of vehicles; optical lenses; materials for electricity mains [wires, cables]; semi-conductors; chips [integrated circuits]; rheostats; electric plugs; electrical adapters; video screens; remote control apparatus; optical fibres [light conducting filaments]; heat regulating apparatus; lightning rods; electrolysers; fire extinguishing apparatus; X-ray apparatus not for medical purposes; protection devices for personal use against accidents; theft prevention installations, electric; spectacles; batteries, electric; battery chargers; mobile power supply [rechargeable battery]; animated cartoons; sports whistles; egg-candlers; dog whistles; decorative magnets; electrified fences; electronic collars to train animals.

Precious metals, unwrought or semi-wrought; jewellery boxes; jewellery; jewellery charms; chronometric instruments; chronometers; clocks and watches, electric; watches; wristwatches; watch bands.

Laundry preparations; soaps; perfumes; essential oils; cosmetics; hair lotions; make-up removing products; lipstick; beauty masks; shaving products.

Electric vehicles; motors, electric, for land vehicles; motorcycle wheel; motorcycles; motorcycle wheel axis holder; mopeds; electric bicycle; electric tricycle; saddle covers for bicycles; vehicle seats.

Medicinal compounds containing cannabis, cannabis derivatives, natural cannabinoids, or synthetic cannabinoids; medicinal compounds containing cannabis, cannabis derivatives, natural cannabinoids, or synthetic cannabinoids for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely, medicinal compounds containing cannabis, cannabis derivatives, natural cannabinoids, or synthetic cannabinoids for treating diseases and medical conditions classified as "orphan" by the US food and drug administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5, 15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy or be; nign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tuberous Sclerosis Complex (TSC), Panayiotopoulos syndrome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; Medicinal herbal extracts for treating disease; Medicinal herbal extracts for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely, medical cannabis and marijuana extracts for treating diseases and medical conditions classified as "orphan" by the US food and drug administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5,15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tuberous ; Sclerosis Complex (TSC), Panayiotopoulos syndrome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; medicinal herbal preparations; medicinal herbal preparations for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely marijuana preparations, cannabis dried flowers and concentrates for treating diseases and medical conditions classified as "orphan" by the US food and drug administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5, 15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), ; Tuberous Sclerosis/Tuberous Sclerosis Complex (TSC), Panayiotopoulos syndrome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; Marijuana derivatives, natural cannabinoids, and synthetic cannabinoids used for treating medical conditions; Marijuana derivatives, natural cannabinoids, and synthetic cannabinoids used for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, managing the effects of chemotherapy, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely liquids, oils, oral sprays, pills, capsules, creams, tinctures, lotions, suppositories, and baked medicinal goods for treating diseases and medical conditions classified as "orphan" by the US food and drug administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5,15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy ; or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tuberous Sclerosis Complex (TSC), Panayiotopoulos syndrome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; medicinal herbs for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5,15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tuberous Sclerosis Complex (TSC), Panayiotopoulos syndrome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in; infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; medicinal herbs in dried or preserved form for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely medical marijuana and cannabis for treating diseases and medical conditions classified as "orphan" by the US food and drug administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5,15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tu; berous Sclerosis Complex (TSC), Panayiotopoulos syndrome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; pills, capsules, infused with cannabis, medical marijuana, natural cannabinoids, or synthetic cannabinoids; extracts and derivatives of cannabis, medical marijuana, natural cannabinoids, and synthetic cannabinoids for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely, salves, concentrates, pastes, extracts, tinctures, marijuana clones, cannabis clones, tissue cultures, powders, juice, resins, oils, and tetrahydrocannabinol (THC) for treating diseases and medical conditions classified as "orphan" by the US food and drug administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5,15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, J; eavons syndrome, Benign Rolandic epilepsy or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tuberous Sclerosis Complex (TSC), Panayiotopoulos syndrome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; suppositories infused with cannabis, medical marijuana, natural cannabinoids, cannabis derivatives, or synthetic cannabinoids; Suppositories infused with cannabis, medical marijuana, cannabis derivatives, natural cannabinoids, or synthetic cannabinoids for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5,15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tuberous Sclerosis Complex (TSC), Panayiotopoulos syndrome, Benig; n Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; transdermal patches infused with cannabis, medical marijuana, marijuana plant derivatives, natural cannabinoids, or synthetic cannabinoids; Transdermal patches infused with cannabis, medical marijuana, marijuana plant derivatives, natural cannabinoids, or synthetic cannabinoids for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5,15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tuberous Sclerosis Complex (TSC), Panayiotopoulos sy; ndrome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; Cannabis, cannabinoids, and medical marijuana based petfoods and medications; Cannabis, cannabinoids, and medical marijuana based pet foods and medications for treating pets for veterinary conditions; edible oils and edible butters containing cannabis, medical marijuana, marijuana plant derivatives, natural cannabinoids, or synthetic cannabinoids; Edible oils and edible butters containing cannabis, medical marijuana plant derivatives, natural cannabinoids, or synthetic cannabinoids for treating headaches, neurodegeneration, neurogenesis, epilepsy, childhood epilepsy, paediatric encephalopathies, pain, cancer, managing the effects of chemotherapy, Tourette Syndrome, post-traumatic stress disorder (PTSD), nausea, vomiting, premenstrual syndrome (PMS), neurologic conditions, sleep disorders, cognitive decline, facial pain, spasms, gastrointestinal diseases, rare diseases, Alzheimer's disease, appetite loss, cancer, Crohn's disease, anorexia, bulimia, epilepsy, glaucoma, schizophrenia, multiple sclerosis, muscle spasms, nausea, pain, headaches, wasting syndrome (cachexia), and diseases classified as "orphan" by the US Food and Drug Administration, namely, Lennox-Gastaut Syndrome, Dravet Syndrome, CDKL5,15q Duplication Syndrome, KCNQ2 related epileptic encephalopathy, SCN8A related epileptic encephalopathy, Electrical status epilepticus in sleep (ESES), Landau-Kleffner syndrome, Continuous spikes and waves during sleep, Tuberous sclerosis complex, Doose Syndrome, Otahara Syndrome, Rett Syndrome, West Syndrome, SYNGAP related epileptic encephalopathy, Fragile X Syndrome, epilepsy with focal cortical dysplasia type II, KCNT1 related epileptic encephalopathy, SCN2A related epileptic encephalopathy, STXBP1 related epileptic encephalopathy, KAND KIF1A related epileptic encephalopathy, HNRNPH2 related epileptic encephalopathy, Phelan-McDermid Syndrome - SHANK3, Angelman Syndrome, Established Status Epilepticus, Refractory Status Epilepticus, Juvenile Myoclonic Epilepsy/Janz Syndrome, Catamenial epilepsy, Drug resistant mesial temporal lobe epilepsy, Occipital Lobe epilepsy, Jeavons syndrome, Benign Rolandic epilepsy or benign childhood epilepsy with centrotemporal spikes (BCECTS), Epilepsy with myoclonic absences, Childhood absence epilepsy (CAE), Tuberous Sclerosis/Tuberous Sclerosis Complex (TSC), Panayiotopoulos synd; rome, Benign Occipital Epilepsy, Idiopathic childhood occipital epilepsy of Gastaut (ICOE-G), Benign myoclonic epilepsy in infancy, Myoclonic astatic epilepsy (MAE), Cornelia de Lange Syndrome (CdLS), Convulsive Seizures, TBI Seizures, Focal Seizures, Generalized onset Seizures, Progressive Myoclonic Epilepsy, Reflex Epilepsy, Abdominal Epilepsy, Photosensitive Epilepsy, Refractory Epilepsy, Automatism Epilepsy, Catamenial epilepsy, Epilepsia partialis continua, Febrile infection-related epilepsy syndrome (FIRES), Migralepsy, Musicogenic epilepsy, Nocturnal Frontal Lobe epilepsy, Occipital Lobe epilepsy, Post-traumatic (TBI) epilepsy (PTE), Temporal lobe epilepsy (TLE), Unverricht-Lundborg disease (abbreviated ULD or EPM1), Vertiginous epilepsy; Cannabis, medical marijuana, marijuana plant derivatives, natural cannabinoids, or synthetic cannabinoids - infused foods for medical purposes, namely, frozen foods, treats, desserts, baked goods, desserts, grain based bars, cakes, cereal bars, cookies, brownies, muffins, cupcakes, chocolate, chocolate confectionery, sugar confectionery, candies, gum, jellies, biscuits, ice cream, sorbet, and frozen bars; beverages infused with medical cannabis, medical marijuana, medical marijuana plant derivatives, medical natural cannabinoids, or medical synthetic cannabinoids.

Providing commercial information to the public in the field of medical cannabis and its use in the treatment of medical conditions.

Supermarket retailing; convenience store retailing; department store retailing; retail sale of prepared meat and meat products (butcher's shop); hypermarket retailing; marketing; promotional marketing; product marketing; direct marketing; marketing consultancy; marketing information; marketing research; marketing assistance; targeted marketing; marketing forecasting; advertising; billboard advertising; advertising agencies; promotional advertising services; promotion (advertising) of business; classified advertising; television advertising; search engine optimisation; search engine optimisation for sales promotion; search engine optimisation services (marketing services); providing user reviews for commercial or advertising purposes; advisory, information and consultancy services in relation to all of the foregoing

Weblog (blog) services (online publication of journals or diaries); providing online videos, not downloadable; providing online electronic publications, not downloadable; online (electronic) publication of news; providing user reviews for entertainment or cultural purposes; arranging of award ceremonies; organisation of galas; organisation of contests (education or entertainment); prize draws (lotteries); electronic publication of information on a wide range of topics, including online and over a global computer network; providing educational information, via a global computer information network in the field of sustainability; arranging and conducting seminars, workshops and conferences; provision of education forums through online forums; production of webcasts for entertainment or education purposes; advisory, information and consultancy services in relation to all of the foregoing